People researching TB-500 tend to ask a similar set of questions. The honest answers are often more useful than the marketing versions found elsewhere online.
Patients researching TB-500 tend to ask the same handful of questions about availability and safety. This article answers them honestly, including what telos rx currently offers and does not offer.
Start the BPC-157 + TB-500 combo intake →Is TB-500 available at telos rx?
Not as a standalone product. telos rx does not currently compound TB-500 on its own because the FDA classified it as a Category 2 bulk substance in late 2023. That classification restricts partner compounding pharmacies from preparing it independently.
telos rx does offer a separately reviewed BPC-157 plus TB-500 combination protocol. This is the single most common point of confusion, so it is worth stating plainly at the top. Standalone availability and combination availability are two different questions with two different answers.
Why do some websites say TB-500 is easy to get?
Some of that information predates the late 2023 classification and simply has not been updated. Other sources are not operating through a licensed compounding pharmacy framework at all, which is a different, riskier situation than a regulated telehealth pathway.
If a source presents standalone TB-500 as freely available through a licensed compounding pathway today, that claim is worth questioning directly rather than assuming it is current or accurate.
What is the BPC-157 plus TB-500 combination, exactly?
It is a distinct formulation that pairs compounded BPC-157 with TB-500, reviewed and prepared by telos rx's partner compounding pharmacies as its own product. It is not the same as receiving TB-500 alone.
It should be considered on its own terms rather than as a substitute for standalone availability. You can read the current details on the BPC-157 + TB-500 combination page.
Will telos rx ever offer TB-500 by itself?
There is no confirmed timeline, and telos rx does not speculate about one. Regulatory classifications can be revisited over time, but nothing about that process is scheduled, and framing it as imminent would be inaccurate.
The accurate, current statement is that standalone TB-500 is not part of the telos rx program today. If that ever changes, telos rx's pages will be updated to reflect it.
What should I do if I am mainly interested in BPC-157?
If your primary interest is BPC-157 rather than TB-500 specifically, telos rx offers standalone compounded BPC-157 as its own product, separate from the combination protocol.
That may be a simpler fit if TB-500 was not the main reason you were researching this topic in the first place. A provider can help you decide during intake.
How do I decide whether the combination protocol is right for me?
That decision depends on your individual history and goals, which is why telos rx routes every intake through review by a licensed provider before anything is approved. A general article cannot answer that question for you, but a provider conversation can.
Bring your specific questions to that conversation rather than assuming a general article covers every scenario relevant to your situation.
Is TB-500 safe?
That question is genuinely hard to answer with confidence, because most available research on TB-500 comes from laboratory and animal studies rather than large controlled human trials. A safety profile in humans has not been firmly established the way it has for approved medications.
This uncertainty is part of the broader picture around TB-500's current regulatory status. It is one reason a licensed provider's individualized judgment matters more than a blanket answer any article, including this one, could offer. It is also part of why standalone TB-500 remains restricted from compounding while the underlying research base continues to develop.
What if I already ordered TB-500 from another source?
If you have already obtained TB-500 from a source outside a licensed compounding pathway, discuss it honestly with a healthcare provider, ideally before using it. A provider can help you think through unknowns around purity, dosing, and interactions with anything else you take.
telos rx cannot verify or endorse a product it did not prescribe or dispense. That is true of any medication sourced outside a regulated pathway, not specific to TB-500 alone.
Does telos rx test for anti-doping compliance?
No. A licensed provider can discuss the medical aspects of a protocol during intake, but verifying whether a specific substance is permitted in a competitive sport is the athlete's own responsibility. Anti-doping rules vary by sport and governing body, and they change over time.
If you compete under a testing program, check your sport's current prohibited list directly rather than assuming that legal availability through a compounding pathway also means it is allowed in competition. Those are separate questions entirely.
How does pricing for the combination protocol work?
Pricing for compounded peptide protocols, including the BPC-157 plus TB-500 combination, is listed on the relevant telos rx product page and can change as the program evolves. Checking the current page directly is more reliable than relying on a number seen elsewhere.
Cost is one factor among several worth weighing, alongside whether a provider believes the protocol fits your history. A lower price from an unregulated source is not a meaningful saving if the product or process behind it cannot be verified.
How long does the intake process take?
telos rx's intake is asynchronous, meaning you complete an online form rather than waiting for a scheduled appointment. Review timelines can vary depending on provider availability and how complete your submitted history is. Checking the current process on telos rx's pages is the most reliable way to know what to expect.
Providing thorough, accurate information during intake tends to make review faster, since a provider is less likely to need follow-up questions before making a decision.
Can I ask my provider questions before deciding?
Yes. Intake is designed to be a two-way conversation, not a one-time form submission. If something in this article, or elsewhere, raises a question specific to your situation, raising it with your provider is the right next step.
A general article, including this one, is meant to give you accurate background information. It is not a substitute for individualized medical guidance, which is why telos rx routes every request through provider review rather than automatic approval.
What happens if my provider does not approve the combination protocol?
Not every request is approved. A licensed provider may determine that the combination protocol is not appropriate for your specific history. That decision is part of the clinical review process working as intended, not a failure on your part.
If that happens, your provider may discuss other options that better fit your goals, which could include standalone BPC-157 or a different available product entirely. Being declined for one protocol does not necessarily rule out others.
Where should I go with questions this article does not cover?
This article covers the questions patients most commonly ask about TB-500 and telos rx's current offering. If your question is not addressed here, telos rx's care team is the right place to ask it directly.
Messaging the care team through the standard intake channel connects you with people who can speak to telos rx's current program specifically. That is more reliable than general information that may not fully apply to your particular situation.
Where to read more, from primary sources
For general background on how the FDA approaches compounding oversight, see the FDA's compounding questions and answers page. For published research involving thymosin beta-4, the natural protein TB-500 is derived from, see this PubMed search of the current literature. Reading primary sources directly is a better habit than relying on secondhand summaries, especially for a peptide whose regulatory status and research base are both still evolving.
Frequently Asked Questions
Does telos rx sell TB-500 by itself?
No. Standalone TB-500 is not currently compounded due to its FDA Category 2 bulk substance classification from late 2023. telos rx offers a separately reviewed BPC-157 plus TB-500 combination instead.
Is the combination protocol just TB-500 with extra steps?
No. It is a distinct formulation combining compounded BPC-157 and TB-500, reviewed and prepared as its own product rather than standalone TB-500 dispensed independently under a different label.
Why do other websites claim TB-500 is easy to order?
Some information online predates the 2023 classification, and other sources may not be operating through a licensed compounding pharmacy framework at all. Neither reflects telos rx's current, regulated offering.
Can a provider make an exception and prescribe standalone TB-500?
No. The restriction applies at the compounding-pharmacy level based on current FDA classification, not at the level of individual provider discretion or patient request.
What if I only want BPC-157, not the combination?
telos rx offers standalone compounded BPC-157 as its own separate product, distinct from the BPC-157 plus TB-500 combination protocol, for patients whose interest is specifically in that peptide alone.
How do I get started if I want to learn more?
Review the BPC-157 plus TB-500 combination page, then start telos rx's online intake so a licensed provider can discuss whether it fits your history and goals directly, and answer any follow-up questions.
telos rx is LegitScript-certified. Compounded medication is not FDA-approved and is prepared under federal compounding regulations by partner compounding pharmacies. This article is general information, not medical advice, and does not replace guidance from your own provider. Approval is subject to evaluation by a licensed provider, and approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service.
Questions about the BPC-157 + TB-500 combination protocol? Message the telos rx care team or read more on the BPC-157 + TB-500 combination page.